We, therefore, performed a case-control study of four SNPs located in the promoter, exonic, and intronic regions of EZH2 to assess the associations between these SNPs and HCC susceptibility and clinicopathologic characteristics. The gene discussed is EZH2; the disease is hepatocellular carcinoma.